Steven A. Haney, PhD, is a Principal Scientist in the Department of Biological Technologies at Wyeth Research, where he has developed programs for oncology drug development, built a HCS program for use in target validation and drug discovery, and prepared gene family-based target validation strategies. Dr. Haney has authored many peer-reviewed articles and has spoken at numerous conferences on HCS.
Preface | |
Contributors | |
Essentials Of High Content Screening. | |
Approaching High Content Screening and Analysis: Practical Advice for Users | |
Introduction | |
What is HCS and Why Should I Care? | |
How does HCS Compare with Current Assay Methods? | |
The Basic Requirements to implement HCS | |
The Process | |
An Example Approach | |
Six Considerations for HCS Assays | |
References | |
Automated High Content Screening Microscopy | |
Introduction | |
Automated HCS Imaging Requirements | |
Components of Automated Imaging Platforms | |
Imaging Platform Software | |
Data Storage and Management | |
Selecting an HCS Platform | |
Comparison of a SAPK Activation HCS Assay Read on an ArrayScanw 3.1, an ArrayScanw VTi, and an IN Cell 3000 Automated Imaging Platform | |
References | |
A Primer on Image Informatics of High Content Screening | |
Background | |
HCS Image Processing | |
Validation | |
Information System Management | |
Data Modeling | |
Conclusions | |
Acknowledgements | |
References | |
Developing Robust High Content Assays | |
Introduction | |
Overview of a Typical Immunofluorescence-Based High Content Assay | |
Identifying Sources of Variability in a High Content Assay | |
From Immunofluorescence to High Content: Selecting the Right Metric | |
Validation of High Content Assays | |
Conclusion | |
Acknowledgements | |
References | |
Section II | |
HCS in Cellular Oncology and Tumor Biology | |
Cancer Cell Biology and HCS | |
The Cell Biology of Cell Death | |
Cell Signaling Pathways in Cancer | |
HCS in Tumor Biology | |
Conclusions | |
References | |
Exploring the Full Power of Combining High Throughput RNAi with High Content Readouts: From Target Discovery Screens to Drug Modifier Studies | |
Background: The Convergence of High Content Analysis and RNAi | |
Integrating HT-RNAi and HCA in Drug Discovery: The Potential | |
Combining RNAi and HCA in one Assay - the Reality | |
HCA-Based RNAi Studies - The Future | |
Acknowledgements | |
References | |
Leveraging HCS in Neuroscience Drug Discovery | |
High Content Screening and Drug Discovery | |
The Neuron and Neuronal Morphology | |
Methods for Measuring Neuronal Morphology | |
Small Molecule Screening for Neurite Outgrowth | |
RNAi in Neuroscience and HCA | |
Measurement of Signal Transduction in Neurons | |
High Content Screening in Complex CNS Models | |
Methods used in Neuronal HCS | |
References | |
Live Brain Slice Imaging for Ultra High Content Screening: Automated Fluorescent Microscopy to Study Neurodegenerative Diseases | |
Introduction and Background | |
Live Brain Slice Model to Study Huntington's Disease | |
Imaging Platforms | |
Center of Well (COW) for Image Processing | |
Generic Protocol for the Cellomics ArrayScan VTI | |
Data and Results | |
Discussion | |
References | |
High Content Analysis of Human Embryonic Stem Cell Growth and Differentiation | |
Introduction | |
Cell Culture Methods | |
Statistical Wavelet Analysis for Stem Cell Classification | |
Molecular Analysis of Pluripotency and Cell Proliferation in Undifferentiated Stem Cells | |
Analysis of Cardiomyocyte Differentiation | |
Analysis of Neuronal Differentiation | |
References | |
HCS IN DRUG DEVELOPMENT. | |
HCS for HTS | |
Introduction | |
HCS for Orphan GPCRS and Transfluor | |
HCS for Multiparameter Cytotoxicity Screening | |
Discussion | |
Summary | |
References | |
The Roles of High Content Cellular Imaging in Lead Optimization | |
Introduction | |
Statistical Validation of Assays | |
High Content Cellular Imaging is a Diverse Assay Platform | |
Use of High Content Cellular Imaging For Oncology Research at Eli Lilly | |
The Future of High Content Cellular Imaging in Lead Optimization | |
Acknowledgements | |
References | |
Using High Content Analysis for Pharmacodynamic Assays in Tissue | |
Introduction | |
Designing a High Content Assay for Use in Tissues | |
Technical Challenges in Establishing High Content Assays for Tissue | |
Case Study: Design and Validation of a High Content Assay for Biomarker X | |
Conclusions | |
Acknowledgements | |
References | |
High Content Analysis of Sublethal Cytotoxicity in Human HepG2 Hepatocytes for Assessing Potential and Mechanism for Chemicaland Drug-Induced Human Toxicity | |
Introduction | |
Results from High Content Analysis of Human Toxicity Potential | |
Discussion | |
Acknowledgements | |
Appendix: Detailed Methods | |
References | |
Data Management, Data Analysis And Systems Biology. | |
Open File Formats for High Content Analysis | |
Introduction | |
The Data Problem in Biology: Why is it so Hard? | |
High Content Data in Biology: A Definition | |
The difference Between a File Format and a Minimum Specification | |
File Formats: Open vs Closed | |
File Formats: Balancing Flexibility with Standards | |
Supporting a Successful File Format | |
Commercial Realities: How Users and Developers can Define File Formats | |
OME-ML and OME-TIFF: Moving Towards a Standard Format For High Content Biological Data | |
Data Model and File Format Integration: Towards Usable Tools | |
Conclusions | |
Acknowledgements | |
References | |
Analysis of Multiparametric HCS Data | |
Cytological Classification and Profiling | |
Setting Up Cytological Profiling Studies | |
Sources of Variability and Corrections | |
General Analysis Considerations | |
Data Analysis Methods | |
Software for HCS Data Analysis | |
Conclusions | |
References | |
Quantitative and Qualitative Cellular Genomics: High Content Analysis as an Endpoint for HT-RNAi Phenotype Profiling Using GE's InCell Platform | |
Cellular Genomics | |
Enabling Technologies to Facilitate Cellular Genomics: RNA Interference | |
High Throughput Rnai (HT-RNAi | |
High Content Analysis (HCA) for High Throughput Phenotype Profiling | |
Future Directions | |
References | |
Optimal Characteristics of Protein-Protein Interaction Biosensors for Cellular Systems Biology Profiling | |
Introduction | |
Challenge of Cellular Systems Biology (CSB | |
Optimal Characteristics of Protein-Protein Interaction Biosensors (PPIBs | |
Example of a PPIB and Cellular Systems Biology Profiling | |
Summary and Prospects | |
Acknowledgements | |
References | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.